Phase II demonstration out of each week irinotecan/cisplatin in cutting-edge esophageal cancer tumors
Phase II demonstration out of each week irinotecan/cisplatin in cutting-edge esophageal cancer tumors Di Lauro L, Fattoruso Lorsque, Giacinti L, et al. Second-line chemotherapy having FOLFIRI inside the patients with metastatic gastric malignant tumors (MGC) perhaps not in earlier times addressed with fluoropyrimidines. J Clin Oncol. 2009. s (suppl; abstr 4549) https://datingmentor.org/escort/nashville/. Burtness B, Gibson […]